Compare
Hesai Group vs Zepp Health Corp
| Latest fiscal year | Hesai Group HSAI | Zepp Health Corp ZEPPLast annual report: year ended 2023-12-31 |
|---|---|---|
| Year ended | 2025-12-31 | 2023-12-31 |
| Revenue | 3.03B CNY | 2.50B CNY |
| Revenue growth (YoY) | +45.8% | -39.8% |
| Gross margin | 41.8% | 26.4% |
| Operating margin | 5.6% | -8.3% |
| Net margin | 14.4% | -8.5% |
| Net income | 435.88M CNY | -212.12M CNY |
| EPS (Diluted) | 2.98 CNY | -0.13 CNY |
| Operating cash flow | 116.99M CNY | 298.67M CNY |
| Free cash flow | -192.38M CNY | 287.37M CNY |
| Cash & equivalents | 1.66B CNY | 949.04M CNY |
| Total assets | 11.26B CNY | 4.51B CNY |
| Total liabilities | 2.30B CNY | 2.01B CNY |
| Shareholders' equity | 8.96B CNY | 2.50B CNY |
| Return on year-end equity | 4.9% | -8.5% |
| Shares outstanding | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Hesai Group | Zepp Health Corp |
|---|---|---|
| Latest | 3.03B CNY Ended 2025-12-31 | 2.50B CNY Ended 2023-12-31 |
| 1 year earlier | 2.08B CNY Ended 2024-12-31 | 4.14B CNY Ended 2022-12-31 |
| 2 years earlier | 1.88B CNY Ended 2023-12-31 | 6.25B CNY Ended 2021-12-31 |
| 3 years earlier | 1.20B CNY Ended 2022-12-31 | 6.43B CNY Ended 2020-12-31 |
| 4 years earlier | 720.77M CNY Ended 2021-12-31 | 5.81B CNY Ended 2019-12-31 |